Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nexia Announces Stock Exchange Listing, PharmAthene Amalgamation Proposal, New BioSteel Patent and Second Quarter 2007 Results

Nexia Biotechnologies Ltd. ("Nexia")(CNQ: NXBL-Z) today provided a corporate update and released financial results for the six-month period ended November 30, 2006.

Nexia Announces Stock Exchange Listing, PharmAthene Amalgamation Proposal, New BioSteel Patent and Second Quarter 2007 Results

EDMONTON, CANADA | Posted on January 22nd, 2007

Corporate Update (in Canadian dollars)

Nexia announced that it will begin trading on Canada's new stock exchange, the CNQ (, on Tuesday, January 23, 2007. Nexia's trading symbol is NXBL.

Today, PharmAthene, Inc. has announced a merger proposal with Health Care Acquisition Corp., which trades on the AMEX under ticker HAQ. Nexia has a significant investment in PharmAthene, Inc. Nexia shareholders are advised to follow developments in this transaction through the public announcements made by PharmAthene ( and by Health Care Acquisition Corp, a U.S. SPAC with over $65 million in cash assets.

Nexia has received an Issue Notification from the United States Patent and Trademark Office, for U.S. Patent No. 7,157,615. This patent strengthens and protects our intellectual property with respect to the production of biofilaments in transgenic animals.

Nexia has shipped transgenic goat milk to the University of Wyoming where BioSteel(R) is being purified and made available for research in industrial, medical device and nanotech applications. Nexia welcomes back Dr. Costas Karatzas, the former Senior VP of R&D of Nexia Biotechnologies Inc., as a consultant, who will assist in pursuing all possible strategies to maximize shareholder value.

The reorganization process with respect to Enseco Energy Services Corp. ("Enseco") was completed in late October 2006. Enseco has confirmed that it has obtained conditional listing approval from the TSX. Nexia shareholders will receive their pro-rata share of 2,125,000 Enseco shares, prior to those
shares beginning to trade.

Second Quarter 2007 Financial Results

The loss for the quarter and six-months ended November 30, 2006 was $289,000 ($0.01 per share). The loss represents operations for the period from the asset transfer on October 23, 2006, from Nexia Biotechnologies Inc., to November 30, 2006. No comparative figures have been presented as Nexia did not have operations in the previous year.


About Nexia
For more information, please visit Nexia's website at . Nexia's complete continuing disclosure documents, including: the second quarter 2007 report and interim financial statements, MD&A, can be accessed through Company's securities filings at .


Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes"; "anticipates"; "intends"; "plans"; "expects"; "estimates"; or similar statements are forward-looking statements. Such statements reflect management's current views and are based on certain assumptions.

Actual results could differ materially from those currently anticipated as a result of a number of factors. Nexia specifically disclaims any obligation to update these forward-looking statements. Nexia assumes no responsibility with respect to any information contained herein relating to any entity other than itself. Website addresses referred to herein are provided for convenience purposes only and information contained therein is not incorporated herein by reference, nor does Nexia assume any responsibility in connection therewith.

For more information, please visit . BioSteel(R) is a registered trademark of Nexia Biotechnologies Ltd. in Canada.

For more information, please click here

David L. Tonken, President, CEO and Chairman of
the Board, (780) 486-2317,

Copyright © CNW Group Ltd.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Ultrathin device harvests electricity from human motion July 23rd, 2017

The July 23 close fly-by of asteroid 2017 BS5 is explored in a Q&A with Dr. John S. Lewis, chief scientist at Deep Space Industries July 23rd, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Pulses of electrons manipulate nanomagnets and store information: Scientists use electron pulses to create and manipulate nanoscale magnetic excitations that can store data July 21st, 2017

Financial Reports

Nanometrics to Announce Second Quarter Financial Results on August 1, 2017 July 14th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Nanometrics to Announce First Quarter Financial Results on May 2, 2017 April 11th, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project